MedTech News
.................... by Andrew Celentano
AI analyzes world’s largest heart attack data sets—and reveals new treatment methods
A landmark international study led by the University of Zurich has shown that artificial intelligence can assess patient risk for the most common type of heart attack more accurately than existing methods. This could enable doctors to guide more personalized treatment decisions for patients.
Smartphone imaging system shows promise for early oral cancer detection in dental clinics
Oral cancer remains a serious health concern, often diagnosed too late for effective treatment, even though the mouth is easily accessible for routine examination. Dentists and dental hygienists are frequently the first to spot suspicious lesions, but many lack the specialized training to distinguish between benign and potentially malignant conditions.
A pill that prints bio-ink for damaged tissue repair
EPFL researchers have demonstrated the first pill-sized bioprinter that can be swallowed and guided within the gastrointestinal tract, where it directly deposits bio-ink over damaged tissues to support repair.
OcuSciences’ eye health diagnostic instrument gains EU CE clearance
The clearance led to the deployment of the instrument across various medical facilities in the UK and Europe.
New brain imaging technique can detect early frontotemporal dementia
A new international study led by researchers at Karolinska Institutet demonstrates that it is possible to detect subtle changes in the brain and identify early signs of hereditary frontotemporal dementia using advanced brain imaging techniques. The study is published in Molecular Psychiatry.
Living brain tissue reveals unique RNA and protein patterns missed in postmortem studies
Two new research papers from the Living Brain Project at Mount Sinai present what is, by several metrics, the largest investigation ever performed of the biology of the living human brain. The papers present unequivocal evidence that brain tissue from living people has a distinct molecular character, an observation that until now was missed because brain tissue from living people is rarely studied.
CAPS Medical’s PlasmaSure™ Receives FDA Breakthrough Device Designation
SANTA MONICA, Calif. and NETANYA, Israel, Oct. 15, 2025 /PRNewswire/ — CAPS Medical, a clinical-stage MedTech company developing a platform for selective tumor ablation across multiple indications, today announced that its PlasmaSure™ System has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the treatment of low- to intermediate-risk non-muscle invasive bladder cancer (NMIBC). The PlasmaSure™ platform delivers non-thermal atmospheric plasma energy through the working channels of standard minimally invasive tools, in the case of NMIBC, through cystoscopes, enabling highly selective, tissue-preserving tumor ablation.
FAU UNVEILS WORLD’S FIRST “BENCH-TO-BEDSIDE” MRI, FOCUSED ULTRASOUND PLATFORM TO ACCELERATE RESEARCH AND TREATMENT OF NEUROLOGICAL DISORDERS
Florida Atlantic University has expanded its NeuroInnovate Center, becoming the first institution globally to integrate advanced MRI and focused ultrasound technologies into a single, unified platform for both preclinical and clinical research. This breakthrough will accelerate the development of non-invasive treatments for neurological disorders such as Alzheimer’s, Parkinson’s and more.